Structural basis for SARM1 inhibition and activation under energetic stress.


Journal

eLife
ISSN: 2050-084X
Titre abrégé: Elife
Pays: England
ID NLM: 101579614

Informations de publication

Date de publication:
13 11 2020
Historique:
received: 11 08 2020
accepted: 12 11 2020
pubmed: 14 11 2020
medline: 17 3 2021
entrez: 13 11 2020
Statut: epublish

Résumé

SARM1, an executor of axonal degeneration, displays NADase activity that depletes the key cellular metabolite, NAD+, in response to nerve injury. The basis of SARM1 inhibition and its activation under stress conditions are still unknown. Here, we present cryo-EM maps of SARM1 at 2.9 and 2.7 Å resolutions. These indicate that SARM1 homo-octamer avoids premature activation by assuming a packed conformation, with ordered inner and peripheral rings, that prevents dimerization and activation of the catalytic domains. This inactive conformation is stabilized by binding of SARM1's own substrate NAD+ in an allosteric location, away from the catalytic sites. This model was validated by mutagenesis of the allosteric site, which led to constitutively active SARM1. We propose that the reduction of cellular NAD+ concentration contributes to the disassembly of SARM1's peripheral ring, which allows formation of active NADase domain dimers, thereby further depleting NAD+ to cause an energetic catastrophe and cell death.

Identifiants

pubmed: 33185189
doi: 10.7554/eLife.62021
pii: 62021
pmc: PMC7688312
doi:
pii:

Substances chimiques

Armadillo Domain Proteins 0
Cytoskeletal Proteins 0
SARM1 protein, human 0
Glycerol PDC6A3C0OX

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Israel Science Foundation
ID : 1425/15
Pays : International
Organisme : Israel Science Foundation
ID : 909/19
Pays : International
Organisme : Elsevier Foundation
ID : Jack and Simon Djanogly Professorial Chair in Biochemistry
Pays : International

Informations de copyright

© 2020, Sporny et al.

Déclaration de conflit d'intérêts

MS, JG, TK, AY, MD, YS, CM, MI, RZ, MH, YO No competing interests declared

Références

J Cell Physiol. 1983 Nov;117(2):230-4
pubmed: 6313704
Science. 2019 Aug 23;365(6455):793-799
pubmed: 31439792
Biochem J. 2012 Mar 1;442(2):263-71
pubmed: 22145856
Proc Natl Acad Sci U S A. 2004 Apr 27;101(17):6593-8
pubmed: 15123841
Life Sci Alliance. 2020 Apr 20;3(5):
pubmed: 32312889
Neuron. 2016 Feb 3;89(3):449-60
pubmed: 26844829
Genes Dev. 2005 Jan 15;19(2):270-81
pubmed: 15625192
Science. 2015 Apr 24;348(6233):453-7
pubmed: 25908823
Neuron. 2017 Mar 22;93(6):1334-1343.e5
pubmed: 28334607
Acta Crystallogr D Struct Biol. 2019 Jun 1;75(Pt 6):528-535
pubmed: 31205015
Acta Crystallogr D Biol Crystallogr. 2010 Jan;66(Pt 1):22-5
pubmed: 20057045
Nucleic Acids Res. 2016 Jul 8;44(W1):W344-50
pubmed: 27166375
Acta Crystallogr D Biol Crystallogr. 2012 Apr;68(Pt 4):431-40
pubmed: 22505263
J Exp Med. 2007 Sep 3;204(9):2063-74
pubmed: 17724133
Nature. 2020 Dec;588(7839):658-663
pubmed: 33053563
Acta Crystallogr D Biol Crystallogr. 2011 Apr;67(Pt 4):235-42
pubmed: 21460441
Science. 2012 Jul 27;337(6093):481-4
pubmed: 22678360
J Immunol. 2013 Jul 15;191(2):875-83
pubmed: 23749635
Nat Methods. 2008 Jan;5(1):53-5
pubmed: 18157137
J Mol Biol. 2019 Sep 6;431(19):3591-3605
pubmed: 31278906
Acta Crystallogr D Biol Crystallogr. 2011 Apr;67(Pt 4):355-67
pubmed: 21460454
J Struct Biol. 2016 Jan;193(1):1-12
pubmed: 26592709
Nat Methods. 2017 Mar;14(3):290-296
pubmed: 28165473
Nat Rev Neurosci. 2020 Apr;21(4):183-196
pubmed: 32152523
J Biol Chem. 2018 Dec 7;293(49):18933-18943
pubmed: 30333228
Nat Immunol. 2006 Oct;7(10):1074-81
pubmed: 16964262
Nat Immunol. 2004 May;5(5):488-94
pubmed: 15048112
Mol Biol Cell. 2013 Sep;24(18):2772-84
pubmed: 23885119
J Neurosci. 2014 Jul 9;34(28):9338-50
pubmed: 25009267
J Neurosci. 2013 Aug 14;33(33):13569-80
pubmed: 23946415
Genomics. 2001 Jun 1;74(2):234-44
pubmed: 11386760
iScience. 2019 May 31;15:452-466
pubmed: 31128467
Brain. 2016 Dec;139(Pt 12):3092-3108
pubmed: 27797810
Curr Protoc Mol Biol. 2003 Aug;Chapter 9:Unit 9.1
pubmed: 18265332
Proc Natl Acad Sci U S A. 2016 Oct 11;113(41):E6271-E6280
pubmed: 27671644
Curr Opin Neurobiol. 2020 Aug;63:59-66
pubmed: 32311648
Cell Rep. 2020 Apr 7;31(1):107498
pubmed: 32268088
J Chem Inf Model. 2020 May 26;60(5):2533-2540
pubmed: 31994878
Endocr Rev. 2010 Apr;31(2):194-223
pubmed: 20007326
PLoS Pathog. 2020 Feb 18;16(2):e1008343
pubmed: 32069324
Acta Crystallogr D Biol Crystallogr. 2010 Apr;66(Pt 4):486-501
pubmed: 20383002
Trends Pharmacol Sci. 2020 Apr;41(4):281-293
pubmed: 32107050
J Mol Biochem. 2012;1(2):76-85
pubmed: 27882309
Cell Rep. 2020 Aug 4;32(5):107999
pubmed: 32755591
Science. 2016 Jun 17;352(6292):1474-7
pubmed: 27313049
Nat Methods. 2013 Jun;10(6):584-90
pubmed: 23644547
Bioessays. 2010 May;32(5):422-9
pubmed: 20414900
J Struct Biol. 2005 Oct;152(1):36-51
pubmed: 16182563
Bio Protoc. 2018 Jul 20;8(14):
pubmed: 30101155
Cell Death Differ. 2015 May;22(5):731-42
pubmed: 25323584
Protein Eng. 1995 Feb;8(2):127-34
pubmed: 7630882
Cell Rep. 2015 Mar 31;10(12):1974-81
pubmed: 25818290
PLoS One. 2019 Mar 15;14(3):e0214000
pubmed: 30875389
Elife. 2016 Oct 13;5:
pubmed: 27735788
Cell Metab. 2018 May 01;27(5):1067-1080.e5
pubmed: 29685734
Acta Crystallogr D Biol Crystallogr. 2001 Oct;57(Pt 10):1451-6
pubmed: 11567159
Proc Natl Acad Sci U S A. 2018 Oct 16;115(42):10654-10659
pubmed: 30257945
J Exp Med. 2019 Feb 4;216(2):294-303
pubmed: 30642945
Elife. 2020 Nov 13;9:
pubmed: 33185189
Nat Methods. 2019 Nov;16(11):1146-1152
pubmed: 31591575
Bioorg Med Chem. 2020 Sep 15;28(18):115644
pubmed: 32828421
Immunity. 2013 Apr 18;38(4):705-16
pubmed: 23499490
Curr Biol. 2018 Feb 5;28(3):421-430.e4
pubmed: 29395922
J Cell Biol. 2020 Aug 3;219(8):
pubmed: 32609299

Auteurs

Michael Sporny (M)

The Mina & Everard Goodman Faculty of Life Sciences, Bar-Ilan University, Ramat-Gan, Israel.

Julia Guez-Haddad (J)

The Mina & Everard Goodman Faculty of Life Sciences, Bar-Ilan University, Ramat-Gan, Israel.

Tami Khazma (T)

The Mina & Everard Goodman Faculty of Life Sciences, Bar-Ilan University, Ramat-Gan, Israel.

Avraham Yaron (A)

Department of Biomolecular Sciences, Weizmann Institute of Science, Rehovot, Israel.

Moshe Dessau (M)

Azrieli Faculty of Medicine, Bar Ilan University, Safed, Israel.

Yoel Shkolnisky (Y)

Department of Applied Mathematics, School of Mathematical Sciences, Tel-Aviv University, Tel-Aviv, Israel.

Carsten Mim (C)

Royal Technical Institute (KTH), Dept. For Biomedical Engineering and Health Systems, Stockholm, Sweden.

Michail N Isupov (MN)

Biosciences, University of Exeter, Exeter, United Kingdom.

Ran Zalk (R)

National Institute for Biotechnology in the Negev, Ben-Gurion University of the Negev, Beer-Sheva, Israel.

Michael Hons (M)

European Molecular Biology Laboratory, Grenoble, France.

Yarden Opatowsky (Y)

The Mina & Everard Goodman Faculty of Life Sciences, Bar-Ilan University, Ramat-Gan, Israel.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH